For gut and liver protection, consider adding oral BPC-157 as a supplemental route
Glucagon-like peptide-1 receptor agonists, more commonly referred to as GLP-1s, are a class of medications that can help manage blood sugar (glucose) levels in individuals living with type 2 diabetes
14 According to our patent searches, Novo Nordisk has filed 91 patents for formulations, 41 patents covering devices to deliver the drug, and 45 patents for methods of treatment (Figure 6)
Amiram M, Luginbuhl KM, Li X, Feinglos MN, Chilkoti A (2013) A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection
It was shown that iron chelator (deferoxamine) and certain antioxidants explicitly inhibit this type of cell death
None of the lesions described have shown evidence of regression